LEADER 03770nam  22004575  450 
001 9910881086803321
005 20240820130258.0
010   $a9783031587993$b(electronic bk.)
010   $z9783031587986
024 7 $a10.1007/978-3-031-58799-3
035   $a(MiAaPQ)EBC31608969
035   $a(Au-PeEL)EBL31608969
035   $a(CKB)34118604500041
035   $a(DE-He213)978-3-031-58799-3
035   $a(EXLCZ)9934118604500041
100   $a20240820d2024      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aClinical Trials in Retinitis Pigmentosa Treatment /$fby Jeffrey N. Weiss
205   $a1st ed. 2024.
210  1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2024.
215   $a1 online resource (281 pages)
311 08$aPrint version: Weiss, Jeffrey N. Clinical Trials in Retinitis Pigmentosa Treatment Cham : Springer,c2024 9783031587986 
320   $aIncludes bibliographical references and index.
327   $aPart 1: Introduction -- Chapter 1. Introduction to Retinitis Pigmentosa -- Chapter 2. Treatments -- Chapter 3. Notes -- Part 2: Completed Clinical Trials -- Chapter 4. United States -- Chapter 5. Brazil -- Chapter 6. Turkey -- Part 3: Active, Recruiting Clinical Trials -- Chapter 7. United States -- Chapter 8. Latin America -- Chapter 9. Turkey -- Part 4: Not Yet Recruiting Clinical Trials -- Chapter 10. Indonesia -- Part 5: Active, Not Recruiting -- Chapter 11. United States -- Chapter 12. France -- Part 6: Enrolling by Invitation -- Chapter 13. United States -- Chapter 14. Indonesia -- Part 7: Gene Therapy Studies -- Chapter 15. United States/Europe -- Chapter 16. India -- Chapter 17. Saudi Arabia -- Part 8: Active, Recruiting Gene Therapy Studies -- Chapter 18. United States -- Chapter 19. China -- Part 9: Active, Not Recruiting Gene Therapy Studies -- Chapter 20. United States -- Chapter 21. Germany -- Chapter 22. Sweden -- Part 10: Enrolling by Invitation Gene Therapy Studies -- Chapter 23. Americas/Europe -- Chapter 24. India -- Part 11: Optogenetics -- Chapter 25. Active Trials in United States -- Part 12: Other Treatments -- Chapter 26. Completed Trials in The Americas/Europe -- Chapter 27. Completed Trials in China -- Chapter 28. Completed Trials in Italy -- Chapter 29. Completed Trials in Turkey -- Chapter 30. Active Trials in the United States -- Chapter 31. Active Trials in Australia -- Chapter 32. Active Trials in China -- Chapter 33. Active, Not Recruiting Trials in the US/Europe -- Chapter 34. Not Yet Recruiting Trials in China.
330   $aThis book is a compendium of the worldwide ocular stem cell, gene therapy, optogenetic, and other miscellaneous studies treating Retinitis Pigmentosa registered with Clinicaltrials.gov. Clinicaltrials.gov is the largest website listing of registered clinical research studies in the world. The study title and the Clinical Trial Number is provided in order to make it easier for the reader to obtain further information. The book contains chapters that act as an introduction to Retinitis Pigmentosa, as well as discussion and analysis of the studies. References are also included for the readers? use. Clinical Trials in Retinitis Pigmentosa Treatment is a valuable resource for ophthalmologists, optometrists, other physicians, and researchers.
606   $aOphthalmology
606   $aOphthalmology
615  0$aOphthalmology.
615 14$aOphthalmology.
676   $a610.724
700   $aWeiss$b Jeffrey N.$0927848
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
912   $a9910881086803321
996   $aClinical Trials in Retinitis Pigmentosa Treatment$94207147
997   $aUNINA